IV Iron Treatments Linked To Anaphylaxis Risk: Study
Injectafer fared better than the competing IV iron supplements, Dexiron and Feraheme, which were three to eight times more likely to cause anaphylaxis.
Injectafer fared better than the competing IV iron supplements, Dexiron and Feraheme, which were three to eight times more likely to cause anaphylaxis.